Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Perfusion CT for Lung Tumors Treated With Stereotactic Ablative Radiation Therapy (SABR)

NCT02693080 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT02693080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02693080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Perfusion CT for Lung Tumors Treated With Stereotactic Ablative Radiation Therapy (SABR)
Lead sponsor
Stanford University
Phase
Phase 1
Overall status
Completed
Start date
January 19, 2016
Completion date
April 29, 2020
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant lung neoplasm, metastatic malignant neoplasm in the lung, non-small cell lung carcinoma, stage iv lung cancer